Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy

Yuting Ma, Sandy Adjemian, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Depending on tumor type, stage and immunological contexture, the inhibition of chemokines or their receptors may yield positive or deleterious effects on disease progression. We have recently demonstrated in several murine models of anthracycline-based chemotherapy that the inhibition of chemokine (C-C motif) ligand 2 (CCL2) or chemokine (C-C motif) receptor 2 (CCR2) may impair the elicitation of anticancer immune responses that contribute to therapeutic success.

Original languageEnglish
Article numbere27663
JournalOncoimmunology
Volume3
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • ATP
  • Autophagy
  • Cancer stem cells
  • Immunogenic cell death
  • Immunosurveillance
  • T lymphocytes
  • γδ

Fingerprint

Dive into the research topics of 'Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy'. Together they form a unique fingerprint.

Cite this